Skip to main content
. 1999 Nov 1;19(21):9271–9280. doi: 10.1523/JNEUROSCI.19-21-09271.1999

Fig. 3.

Fig. 3.

Dose-dependent effect of hCB1 cDNA on signaling by receptors for norepinephrine and somatostatin. Bar graph of control Ca2+ current inhibition by norepinephrine (NE, open bars) and somatostatin (SOM, diagonal bars) in uninjected SCG neurons (Uninjected) and in neurons microinjected with 10, 50, and 100 ng/μl hCB1 cDNA (hCB1). Microinjection of 50 ng/μl hCB1 cDNA significantly reduced (*p < 0.05) the inhibition of the Ca2+ current by both norepinephrine and somatostatin. Microinjection of 100 ng/μl hCB1 cDNA abolished (**p < 0.001) the inhibition of the Ca2+ current by both norepinephrine and somatostatin. The number of neurons tested is indicated.

HHS Vulnerability Disclosure